{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:19:28Z","timestamp":1782771568946,"version":"3.54.5"},"reference-count":96,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone &amp; IGF Research"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.ghir.2003.09.003","type":"journal-article","created":{"date-parts":[[2003,11,27]],"date-time":"2003-11-27T07:12:55Z","timestamp":1069917175000},"page":"1-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Endocrine and metabolic aspects of adult Prader\u2013Willi syndrome with special emphasis on the effect of growth hormone treatment"],"prefix":"10.1016","volume":"14","author":[{"given":"Charlotte","family":"H\u00f6ybye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2003.09.003_BIB1","first-page":"1260","article-title":"Ein Syndrom von Adipositas Kleinwuchs,Kryptorchismus und Oligophrenie nach myotonieartigen Zustand im Neugeborenalter","volume":"86","author":"Prader","year":"1956","journal-title":"Schweiz Med. Wochenschr."},{"key":"10.1016\/j.ghir.2003.09.003_BIB2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1542\/peds.91.2.398","article-title":"Prader\u2013Willi syndrome: consensus diagnostic criteria","volume":"91","author":"Holm","year":"1993","journal-title":"Pediatrics"},{"key":"10.1016\/j.ghir.2003.09.003_BIB3","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1136\/jmg.34.11.917","article-title":"Prader\u2013Willi syndrome","volume":"34","author":"Cassidy","year":"1997","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ghir.2003.09.003_BIB4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/edrv.22.6.0447","article-title":"Endocrine dysfunction in Prader\u2013Willi syndrome: a review with special reference to GH","volume":"22","author":"Burman","year":"2001","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2003.09.003_BIB5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00005792-198303000-00001","article-title":"The Prader\u2013Willi syndrome. A study of 40 patients and a review of the literature","volume":"62","author":"Bray","year":"1983","journal-title":"Medicine"},{"key":"10.1016\/j.ghir.2003.09.003_BIB6","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s004310050901","article-title":"Reference values for height and weight in Prader\u2013Willi syndrome based on 315 patients","volume":"57","author":"Wollman","year":"1998","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ghir.2003.09.003_BIB7","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1651-2227.2000.tb00755.x","article-title":"Spontaneous growth in German children and adolescents with genetically confirmed Prader\u2013Willi syndrome","volume":"89","author":"Hauffa","year":"2000","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ghir.2003.09.003_BIB8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/1098-2779(2000)6:2<125::AID-MRDD6>3.0.CO;2-T","article-title":"Appetite behaviour, compulsivity, and neurochemistry in Prader\u2013Willi syndrome","volume":"6","author":"Dimitropoulos","year":"2000","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"issue":"8","key":"10.1016\/j.ghir.2003.09.003_BIB9","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1469-7610.1996.tb01496.x","article-title":"Obsessions and compulsions in Prader\u2013Willi syndrome","volume":"37","author":"Dykens","year":"1996","journal-title":"J. Child Psychol. Psychiat."},{"key":"10.1016\/j.ghir.2003.09.003_BIB10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1651-2227.1999.tb14418.x","article-title":"Glucose homeostasis in Prader\u2013Willi syndrome and potential implications of growth hormone therapy","volume":"443","author":"Zipf","year":"1999","journal-title":"Acta Paediatr. (Suppl.)"},{"key":"10.1016\/j.ghir.2003.09.003_BIB11","first-page":"351","article-title":"Body composition during GH treatment in Prader\u2013Willi syndrome","volume":"12","author":"Bosio","year":"1999","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.09.003_BIB12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1469-8749.1987.tb02129.x","article-title":"Adults with Prader\u2013Willi syndrome. A survey of 232 cases","volume":"29","author":"Greenswag","year":"1987","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ghir.2003.09.003_BIB13","first-page":"573","article-title":"Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons in Prader\u2013Willi syndrome: a study of five cases","volume":"80","author":"Swaab","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.09.003_BIB14","doi-asserted-by":"crossref","unstructured":"P.V. Caroll, E.R. Christ, and the members of Growth Hormone Research Society Scientific Committee, Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review, J. Clin. Endocrinol. Metab. 83 (1998) 382\u2013395","DOI":"10.1210\/jc.83.2.382"},{"key":"10.1016\/j.ghir.2003.09.003_BIB15","first-page":"195","article-title":"Cardiovascular risk factors in adult patients with growth hormone deficiency","volume":"129","author":"Ros\u00e9n","year":"1993","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"10.1016\/j.ghir.2003.09.003_BIB16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2265.1997.d01-1749.x","article-title":"Increased cardiovascular mortality in patients with hypopituitarism","volume":"46","author":"Bulow","year":"1997","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2003.09.003_BIB17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJM198102053040604","article-title":"Deletions of chromosome 15 as a cause of the Prader\u2013Willi syndrome","volume":"304","author":"Ledbetter","year":"1981","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2003.09.003_BIB18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/342281a0","article-title":"Genetic imprinting suggested by maternal heterodisomy in non-deletion Prader\u2013Willi syndrome","volume":"342","author":"Nicholls","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.ghir.2003.09.003_BIB19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1089\/109065700750065144","article-title":"Prader\u2013Willi syndrome: genetic tests and clinical findings","volume":"4","author":"Fridman","year":"2000","journal-title":"Genet. Test"},{"key":"10.1016\/j.ghir.2003.09.003_BIB20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev.genom.2.1.153","article-title":"Genome organization, function, and imprinting in Prader\u2013Willi and Angelman syndromes","volume":"2","author":"Nicholls","year":"2001","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.ghir.2003.09.003_BIB21","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1210\/jcem.87.4.8414","article-title":"Benefits of long-term GH therapy in Prader\u2013Willi syndrome: a 4 year study","volume":"87","author":"Carrel","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.09.003_BIB22","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1210\/jcem.87.8.8735","article-title":"Metabolic profile and body composition in adults with Prader\u2013Willi syndrome and severe obesity","volume":"87","author":"H\u00f6ybye","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.09.003_BIB23","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1046\/j.1365-2265.2003.01769.x","article-title":"Growth hormone treatment improves body composition in adults with Prader\u2013Willi syndrome","volume":"58","author":"H\u00f6ybye","year":"2003","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2003.09.003_BIB24","doi-asserted-by":"crossref","unstructured":"Anon., The health implications of obesity, National Institutes of Health Consensus Development Statement, Ann. Intern. Med. 103 (1985) 979\u20131077","DOI":"10.7326\/0003-4819-103-6-1073"},{"key":"10.1016\/j.ghir.2003.09.003_BIB25","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1136\/bmj.288.6428.1401","article-title":"Abdominal adipose tissue distribution, obesity and risk of cardiovascular disease and death: 13 year follow-up of participants in the study of men born in 1913","volume":"388","author":"Larsson","year":"1984","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ghir.2003.09.003_BIB26","first-page":"781","article-title":"Comparisons between Hologic, Lunar and Norland dual X-ray absorptiometers and other techniques used for whole-body soft tissue measurements","volume":"48","author":"Tothill","year":"1994","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.ghir.2003.09.003_BIB27","unstructured":"Anon., Assessment of fracture risk and its application to screening for postmenopausal osteoporosis, Geneva, WHO Tech. Rep. Ser. (1994) 843"},{"key":"10.1016\/j.ghir.2003.09.003_BIB28","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.ghir.2003.09.003_BIB29","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s001250051561","article-title":"Assesment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerence test","volume":"43","author":"Albareda","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.ghir.2003.09.003_BIB30","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.2337\/diabetes.47.10.1643","article-title":"Prevalence of insulin resistance in metabolic disorders. The Bruneck Study","volume":"47","author":"Bonora","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2003.09.003_BIB31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1651-2227.1996.tb13991.x","article-title":"Diagnosis of the Prader\u2013Willi syndrome by proving the absence of unmethylated PW71 DNA fragment","volume":"85","author":"Lindgren","year":"1996","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ghir.2003.09.003_BIB32","first-page":"563","article-title":"Comparison of acid ethanol extraction and acid gel filtration prior to IGF-1 and IGF-2 radioimmunoassays: Improvement of determination in acid ethanol extracts by the use of truncated IGF-1 as radioligand","volume":"107","author":"Bang","year":"1991","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"10.1016\/j.ghir.2003.09.003_BIB33","first-page":"2013","article-title":"Serum levels of insulin-like growth factor 1 in 152 patients with growth hormone deficiency, aged 19\u201382 years, in relation to those in healthy subjects","volume":"84","author":"Hilding","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.09.003_BIB34","first-page":"563","article-title":"Crossreaction of somatomedin-binding protein in a radioimmunoassay developed for somatomedin binding protein isolated from human amniotic fluid","volume":"107","author":"Povoa","year":"1984","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"10.1016\/j.ghir.2003.09.003_BIB35","first-page":"169","article-title":"Non-competitive time-resolved immunofluorometric assay for determination of human insulin-like growth factor I and II","volume":"5","author":"Frystyk","year":"1995","journal-title":"Growth Regul."},{"key":"10.1016\/j.ghir.2003.09.003_BIB36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0014-5793(94)00602-4","article-title":"Free insulin-like growth factors (IGF-I and IGF-II) in human serum","volume":"348","author":"Frystyk","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ghir.2003.09.003_BIB37","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2362.1996.2010558.x","article-title":"A simple, rapid immunometric assay for determination of functional and growth hormone occupied GH-binding protein in human serum","volume":"26","author":"Fisker","year":"1996","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.ghir.2003.09.003_BIB38","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1210\/jc.2002-021349","article-title":"Free and total insulin-like growth factor (IGF)-I, II, and IGF-binding protein-1, -2, and -3 serum levels in patients with active thyroid eye disease","volume":"88","author":"Krassas","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.09.003_BIB39","first-page":"213","article-title":"Elevated plasma levels of oxytocin in obese subjects before and after gastric banding","volume":"13","author":"Stock","year":"1989","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.ghir.2003.09.003_BIB40","doi-asserted-by":"crossref","unstructured":"Anon., Prevention of coronary heart disease in clinical practise, Recommendations of the second joint task force of European and other societies on coronary prevention, Eur. Heart J. 19 (1998) 1434\u20131503","DOI":"10.1053\/euhj.1998.1243"},{"key":"10.1016\/j.ghir.2003.09.003_BIB41","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ghir.2003.09.003_BIB42","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1096-6374(03)00017-0","article-title":"The growth hormone-insulin-like growth factor axis in adult patients with Prader\u2013Willi syndrome","volume":"13","author":"H\u00f6ybye","year":"2003","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2003.09.003_BIB43","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/(SICI)1520-7560(199909\/10)15:5<314::AID-DMRR56>3.0.CO;2-E","article-title":"Circulating levels of free Insulin-like growth factors in obese subjects: the impact of type 2 diabetes","volume":"15","author":"Frystyk","year":"1999","journal-title":"Diabetes Metab. Rev."},{"key":"10.1016\/j.ghir.2003.09.003_BIB44","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s004310050961","article-title":"Low insulin, IGF-1 and IGFBP-3 levels in children with Prader\u2013Labhart\u2013Willi syndrome","volume":"157","author":"Eiholzer","year":"1998","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ghir.2003.09.003_BIB45","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1046\/j.1365-2265.1998.00435.x","article-title":"Reduced growth hormone (GH) responsiveness to combined GH-releasing hormone and pyridostigmine administration in the Prader\u2013Willi syndrome","volume":"48","author":"Grugni","year":"1998","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2003.09.003_BIB46","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1515\/JPEM.1996.9.3.393","article-title":"Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader\u2013Willi syndrome","volume":"9","author":"Angulo","year":"1996","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.09.003_BIB47","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1651-2227.1998.tb01380.x","article-title":"Growth Hormone treatment of children with Prader\u2013Willi syndrome affects linear growth and body composition favourably","volume":"87","author":"Lindgren","year":"1998","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ghir.2003.09.003_BIB48","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/PL00008349","article-title":"Cardiovascular risk factors improve under 3 years of growth hormone therapy in Prader\u2013Willi syndrome","volume":"159","author":"l\u2019Allemand","year":"2000","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ghir.2003.09.003_BIB49","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0022-3476(73)80219-7","article-title":"Immunoreactive insulin and growth hormone responses in patients with Prader\u2013Willi syndrome","volume":"83","author":"Parra","year":"1973","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ghir.2003.09.003_BIB50","first-page":"44","article-title":"Is there growth hormone deficiency in Prader\u2013Willi syndrome?","volume":"53","author":"Eiholzer","year":"2000","journal-title":"Horm. Res. (Suppl.)"},{"key":"10.1016\/j.ghir.2003.09.003_BIB51","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1515\/JPEM.1991.4.3.167","article-title":"Pituitary evaluation and growth hormone treatment in Prader\u2013Willi syndrome","volume":"4","author":"Angulo","year":"1991","journal-title":"J. Pediatr. Endocrinol."},{"key":"10.1016\/j.ghir.2003.09.003_BIB52","first-page":"201","article-title":"Body composition studies in Prader\u2013Willi syndrome (PWS): effects of growth hormone (GH) therapy","volume":"60","author":"Lee","year":"1993","journal-title":"Basic Life Sci."},{"key":"10.1016\/j.ghir.2003.09.003_BIB53","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1530\/eje.0.1440283","article-title":"Circulating IGF binding protein-1 is inversely associated with leptin in non-obese men and obese postmenopausal women","volume":"144","author":"S\u00f6derberg","year":"2001","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2003.09.003_BIB54","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.ijo.0800412","article-title":"Effect of obesity on total and free insulin-like growth factor (IGF-I), and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, and growth hormone","volume":"21","author":"Nam","year":"1997","journal-title":"Int. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.ghir.2003.09.003_BIB55","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0026-0495(95)90219-8","article-title":"Free insulin-like growth factors in human obesity","volume":"44","author":"Frystyk","year":"1995","journal-title":"Metabolism"},{"key":"10.1016\/j.ghir.2003.09.003_BIB56","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/ajcn\/65.5.1369","article-title":"Peculiar body composition in patients with Prader\u2013Labhart\u2013Willi syndrome","volume":"65","author":"Brambilla","year":"1997","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ghir.2003.09.003_BIB57","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1210\/jcem.86.9.7814","article-title":"Visceral adipose tissue and metabolic complications of obesity are reduced in Prader\u2013Willi syndrome female adults: evidence for novel influences on body fat distribution","volume":"86","author":"Goldstone","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.09.003_BIB58","first-page":"1020","article-title":"What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?","volume":"86","author":"Brouchu","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.09.003_BIB59","doi-asserted-by":"crossref","unstructured":"E.A.H. Sims, Are there persons who are obese, but metabolically healthy? Metabolism 50 (21001) 1499\u20131504","DOI":"10.1053\/meta.2001.27213"},{"key":"10.1016\/j.ghir.2003.09.003_BIB60","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1530\/eje.0.1330180","article-title":"Reduced bone mineral density in adults with growth hormone (GH) deficiency: increased bone turnover during 12 months of GH substitution therapy","volume":"133","author":"Degerblad","year":"1995","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2003.09.003_BIB61","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(89)92328-3","article-title":"Beneficial effects of growth hormone treatment in GH-deficient adults","author":"Jorgensen","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2003.09.003_BIB62","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1210\/jcem.84.11.6088","article-title":"The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults","volume":"84","author":"Bengtsson","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.09.003_BIB63","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2265.1997.3271123.x","article-title":"Individualized dose titration of growth hormone (GH) replacement in hypopituitary adults","volume":"47","author":"Johannsson","year":"1997","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2003.09.003_BIB64","first-page":"157","article-title":"Growth hormone treatment of children with Prader\u2013Willi syndrome: effects on glucose and insulin homeostasis. Swedish National Growth Hormone Advisory Group","volume":"1","author":"Lindgren","year":"1995","journal-title":"Horm. Res."},{"key":"10.1016\/j.ghir.2003.09.003_BIB65","doi-asserted-by":"crossref","unstructured":"Growth Hormone Research Society, Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency, J. Clin. Endocrinol. Metab. 83 (1998) 379\u2013395","DOI":"10.1210\/jc.83.2.379"},{"key":"10.1016\/j.ghir.2003.09.003_BIB66","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2165\/00002018-200225030-00005","article-title":"Growth hormone therapy and its relationship to insulin resistance, glucose intolerance and diabetes mellitus: a review of recent evidence","volume":"25","author":"Jeffcoate","year":"2002","journal-title":"Drug Saf."},{"key":"10.1016\/j.ghir.2003.09.003_BIB67","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0026-0495(96)90181-X","article-title":"Characterisation of alterations in glucose and insulin metabolism in Prader\u2013Willi subjects","volume":"45","author":"Scuster","year":"1996","journal-title":"Metabolism"},{"key":"10.1016\/j.ghir.2003.09.003_BIB68","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/0026-0495(93)90145-E","article-title":"GH treatment improves serum lipids and lipoproteins in adults with GHD","volume":"42","author":"Cuneo","year":"1991","journal-title":"Metabolism"},{"key":"10.1016\/j.ghir.2003.09.003_BIB69","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/01.ATV.13.2.296","article-title":"GH treatment of GHD adults results in a marked increase in Lp (a) and HDL cholesterol concentrations","volume":"13","author":"Ed\u00e9n","year":"1993","journal-title":"Arterioscl. Thromb."},{"key":"10.1016\/j.ghir.2003.09.003_BIB70","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1136\/bmj.306.6894.1726-a","article-title":"Increased concentration of serum lipoprotein (a) in response to GH treatment","volume":"306","author":"Olivecrona","year":"1993","journal-title":"Brit. Med. J."},{"key":"10.1016\/j.ghir.2003.09.003_BIB71","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0002-9378(11)90604-8","article-title":"Lp (a) lipoprotein: relationship to cardiovascular disease risk factors and estrogen","volume":"166","author":"Lobo","year":"1992","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ghir.2003.09.003_BIB72","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1365-2796.2001.00889.x","article-title":"The importance of the relation between lipoprotein (a) and lipids for developing atherosclerosis and cardiovascular disease","volume":"250","author":"Dahl\u00e9n","year":"2001","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ghir.2003.09.003_BIB73","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.ijo.0801175","article-title":"Activity related energy expenditure in children and adolescents with Prader\u2013Willi syndrome","volume":"24","author":"van Mil","year":"2000","journal-title":"Int. J. Obes. Relat. Metab. Disorder"},{"issue":"2","key":"10.1016\/j.ghir.2003.09.003_BIB74","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0026-0495(98)90003-8","article-title":"Energy expenditure and body composition in Prader\u2013Willi syndrome","volume":"37","author":"Schoeller","year":"1988","journal-title":"Metabolism"},{"key":"10.1016\/j.ghir.2003.09.003_BIB75","unstructured":"V.S. Herman-Bonert, D. Prager, S. Melmed, Growth hormone, GH and metabolism, The Pituitary, Blackwell Science, Cambridge, MA, 1995, pp. 112\u2013113"},{"key":"10.1016\/j.ghir.2003.09.003_BIB76","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1067\/mpd.2000.106563","article-title":"Eating behaviour in Prader\u2013Willi syndrome, normal weight and obese control groups","volume":"137","author":"Lindgren","year":"2000","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ghir.2003.09.003_BIB77","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/35007534","article-title":"Central nervous control of food intake","volume":"404","author":"Schwartz","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ghir.2003.09.003_BIB78","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0024-3205(86)90061-5","article-title":"Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system","volume":"38","author":"Gray","year":"1986","journal-title":"Life Sci."},{"key":"10.1016\/j.ghir.2003.09.003_BIB79","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.ghir.2003.09.003_BIB80","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone releasing acytylated peptide from the stomach","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ghir.2003.09.003_BIB81","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/jcem.86.12.8111","article-title":"Ghrelin enhances appetite and increases food intake in humans","volume":"86","author":"Wren","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9 Suppl","key":"10.1016\/j.ghir.2003.09.003_BIB82","first-page":"73S","article-title":"Feeding acutely suppresses ghrelin levels in normal weight human subjects","volume":"3","author":"Caixas","year":"2001","journal-title":"Obes. Res."},{"key":"10.1016\/j.ghir.2003.09.003_BIB83","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.2337\/diabetes.50.8.1714","article-title":"A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans","volume":"50","author":"Cummings","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2003.09.003_BIB84","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nm0702-643","article-title":"Elevated plasma ghrelin levels in Prader\u2013Willi syndrome","volume":"7","author":"Cummings","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ghir.2003.09.003_BIB85","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1210\/jc.2002-020871","article-title":"High circulating ghrelin: a potential cause for hyperphagia and obesity in Prader\u2013Willi syndrome","volume":"87","author":"DelParigi","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.09.003_BIB86","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0031-9384(81)90366-8","article-title":"Hypothalamic paraventricular nucleus lesions produce overeating and obesity in the rat","volume":"27","author":"Leibowitz","year":"1981","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ghir.2003.09.003_BIB87","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0196-9781(91)90176-P","article-title":"Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats","volume":"12","author":"Olsson","year":"1991","journal-title":"Peptides"},{"key":"10.1016\/j.ghir.2003.09.003_BIB88","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/jcem.87.1.8129","article-title":"Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion","volume":"87","author":"Shiiya","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.09.003_BIB89","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2337\/diabetes.50.4.707","article-title":"Circulating ghrelin levels are decreased in human obesity","volume":"50","author":"Tschoep","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2003.09.003_BIB90","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.1210\/jcem.86.9.8003","article-title":"Plasma ghrelin concentration and energy balance: overfeeding and negative energy balance studies in twins","volume":"86","author":"Ravussin","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.09.003_BIB91","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/nm1195-1155","article-title":"Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects","volume":"1","author":"Maffei","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.ghir.2003.09.003_BIB92","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1210\/jcem.87.2.8230","article-title":"Hypothalamic NPY and agouti-related protein are increased in human illness but not in Prader\u2013Willi syndrome and other obese subjects","volume":"87","author":"Goldstone","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.09.003_BIB93","doi-asserted-by":"crossref","unstructured":"C. H\u00f6ybye, B. Barkeling, U. Espelund, M. Petersson, M. Thor\u00e9n, Peptides associated with hyperphagia in adults with Prader\u2013Willi syndrome before and during growth hormone treatment, Growth Horm. IGF Res. (2003), in press","DOI":"10.1016\/S1096-6374(03)00077-7"},{"key":"10.1016\/j.ghir.2003.09.003_BIB94","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1210\/jc.2002-021052","article-title":"Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader\u2013Willi syndrome","volume":"88","author":"Haqq","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.09.003_BIB95","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1530\/eje.0.1450711","article-title":"Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy","volume":"145","author":"Janssen","year":"2001","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2003.09.003_BIB96","first-page":"66","article-title":"Leptin concentrations in PWS before and after growth hormone replacement","volume":"52","author":"Meyers","year":"2000","journal-title":"Clin. Endocrinol. (Oxf.)"}],"container-title":["Growth Hormone &amp; IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637403001369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637403001369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:39:49Z","timestamp":1761086389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637403001369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S1096637403001369"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2003.09.003","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocrine and metabolic aspects of adult Prader\u2013Willi syndrome with special emphasis on the effect of growth hormone treatment","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2003.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}